If you are thinking about selling your medical or healthcare practice in Boston, you are likely navigating one of the most significant financial decisions of your life. Most advisors will tell you about the process. Our founder has lived it, as a seller, a buyer, and a founder who had to figure out what came next.
Buyers of a medical practice evaluate payer mix, provider dependency, referral relationships, and the compliance and credentialing picture that sits beneath the financials. A practice that depends entirely on the selling physician's personal production is a very different asset from one with associate providers, durable referral patterns, and systems that transfer. Hospital systems, private equity backed groups, and individual clinicians all buy differently, and preparing for the right buyer type often matters as much as the asking price. Boston's dense hospital ecosystem shapes practice sales here: buyers range from academic-affiliated systems to private groups, and referral relationships carry unusual weight in valuation.
Boston's buyer pool is unusually sophisticated, with search fund operators and well-capitalized individuals who know exactly what they are looking at, so diligence here is rigorous and these drivers get tested hard.
Payer mix, contracts, and compliance. Beneath the financials sit the things buyers refuse to inherit: credentialing gaps, payer contracts that do not assign on a change of control, coding and compliance questions with no documentation. These are not risks a buyer can price; they are liabilities that stall or kill deals late. Finding them first, and fixing or framing them, is the cheapest insurance in a practice sale.
Provider dependency and referral durability. Referral relationships are the quiet asset in a practice sale. When they are documented, distributed across providers, and durable beyond the founder, a buyer can model them; when they live in one physician's phone, the buyer discounts them and structures the deal to protect against losing them.
The buyer type shapes the deal. The headline number is where the conversation starts. What you collect, on what schedule, with what still at risk, depends on the buyer and the structure: cash at closing, a seller note, an earnout on production you no longer control. We reduce every offer to expected cash, adjusted for risk, timing, and tax, and compare those numbers instead of the headlines.
Three of our Insights articles unpack this: why buyers discount owner dependence so heavily, the red flags that kill deals in the final stretch, and earnouts, seller notes, and the structure behind the headline number.
Boston's economy is anchored by education, healthcare, technology, and financial services, which produces one of the deepest pools of sophisticated buyers in the country. The region's business schools graduate search fund operators every spring who are explicitly hunting for established companies to buy and run, and the area's concentration of wealth means individual acquirers here are unusually well capitalized. Diligence in this market is rigorous and buyers know what they are looking at, which cuts both ways: well-run businesses with clean financials command real attention and strong terms, while unprepared sellers get found out quickly.
We work with owners across Florida and nationwide. Whether you are in Boston or anywhere in between, we bring the same preparation-first approach to every engagement. Pedro has built and sold businesses of his own, and acquired and sold others: that experience is what we bring to your side of the table.
We start with preparation, not a listing. That means a value range built on your actual earnings and current comparables rather than a flattering number, and an honest read on which of the drivers above are working for you and which a buyer will hold against you. Then we market the business without exposing its identity. Your employees, clients, and competitors in Boston should never learn a sale is being considered, and confidentiality agreements come before any meaningful disclosure.
Not every interested party is a buyer. We screen for financial capacity, genuine intent, and fit before sharing sensitive information, so your time goes to the operators, searchers, or acquirers who can close on a medical practice like yours. Diligence is where most deals actually die, so we treat it as a process to manage rather than a phase to survive: organized responses, no surprises, and offers evaluated on terms, contingencies, and real cash at closing. Read how we work, from first call to closing.
Learn more about our M&A advisory approach, or explore other markets we serve.
An initial consultation is free. We will tell you honestly where your business stands and what it would take to go to market at the right time and the right price.